Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Brian MacArthur

Raymond James · covers Basic Materials

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters; questions recorded in 5).

Limited coverage. Only 7 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
7on tracked calls
Challenge rate
0%none of 7 questionsLimited sample
Companies
1questioned at least once
Reporting periods
5with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 7 of 7 questions from 1 company

FCXFreeport-McMoRan7 questions · 5 reporting periods · 0 of 7 challenging
FCX company page →

Calendar 2026 Q2

have you changed your assumptions for molybdenum in these economic And if so, what molybdenum price are you using?

PricingCapex InvestmentTranscript · FY2026 Q2 →
Show response

Confirmed the $4 copper incentive case uses a conservative $20 moly price despite molybdenum trading materially higher.

Calendar 2025 Q4

I see there's no export duties when I look at your guidance going forward, TCs are up to $0.43 versus historical levels

Cost PressureRegulation PolicyTranscript · FY2025 Q4 →
Show response

Quirk confirmed zero export duties going forward as all concentrate processed internally. The $0.43 TC reflects internal smelter operating costs plus tolling fees. Revenue line now captures full byproduct and free metal benefits.

Is that all additive post-2030, i.e., the higher production at KL, you still have the mill capacity, you have to do anything?

Capex InvestmentSupply ChainTranscript · FY2025 Q4 →
Show response

Quirk explained KL rates increased from 90,000 to 130,000 tons/day by substituting KL ore for GBC ore that requires pyrite processing, deferring capital for pyrite handling facilities. This is timing resequencing, not net new production.

Calendar 2025 Q2

do you think you're going to be able to get up to the current recoveries you see at GBC

Innovation & R&DRevenue GrowthTranscript · FY2025 Q2 →
Show response

Quirk acknowledged KL recoveries remain below GBC levels but improvements have been made. Current reserve assumptions are conservative relative to actual GBC mill recoveries.

if I look past the 5 years, is there anything different I should worry about there?

Supply ChainGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Quirk confirmed no change to long-range plans. KL development adds optionality for grade sequencing between ore bodies. 2041 extension would open additional recovery opportunities.

Calendar 2025 Q1

did you make an assumption that the 7.5% export tax went away in the fourth quarter in Indonesia

Cost PressureRegulation PolicyTranscript · FY2025 Q1 →
Show response

Quirk confirmed no export duty projected in Q4 since internal smelters will process concentrate. Indonesia unit cost improved from -27 cents to -47 cents credit mainly from higher gold prices.

Calendar 2024 Q4

Is that going to happen even if you get the smelter up and running or is it still working the way it used to work

Regulation PolicyCost PressureTranscript · FY2024 Q4 →
Show response

Quirk confirmed 7.5% export duty applies on all 2025 exports per current regulation. Exports decline significantly in H2 as smelter ramps up. 2026 target is zero export duty.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
FCX Freeport-McMoRan70%none of 7 questions
  • FCX
    Freeport-McMoRan · 7 questions
    0%none of 7 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q410%none of 1 question1
2025 Q110%none of 1 question1
2025 Q220%none of 2 questions1
2025 Q3No questions recorded——
2025 Q420%none of 2 questions1
2026 Q1No questions recorded——
2026 Q210%none of 1 question1
  1. 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q11 question · challenge rate 0% (none of 1 question) · 1 company
  3. 2025 Q22 questions · challenge rate 0% (none of 2 questions) · 1 company
  4. 2025 Q3No questions recorded
  5. 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
  6. 2026 Q1No questions recorded
  7. 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Cost Pressure3
  • Regulation Policy3
  • Capex Investment2
  • Supply Chain2
  • Pricing1
  • Innovation & R&D1
  • Revenue Growth1
  • Guidance Reliability1